Clinical Trial Update: Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cediranib with paclitaxel or cediranib with olaparib for advanced endometrial cancer; status unavailable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinosarcoma
• Endometrial Neoplasms

Drugs mentioned

• Cediranib (Cediranib)
• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Manchester | Conditions: Carcinosarcoma, Endometrial Neoplasms | Phase 2 | Status: UNKNOWN